vs

Side-by-side financial comparison of NeuroPace Inc (NPCE) and Virginia National Bankshares Corp (VABK). Click either name above to swap in a different company.

NeuroPace Inc is the larger business by last-quarter revenue ($26.6M vs $15.0M, roughly 1.8× Virginia National Bankshares Corp). Virginia National Bankshares Corp runs the higher net margin — 39.7% vs -10.3%, a 49.9% gap on every dollar of revenue. On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs 3.6%). Virginia National Bankshares Corp produced more free cash flow last quarter ($20.8M vs $409.0K). Over the past eight quarters, NeuroPace Inc's revenue compounded faster (21.1% CAGR vs 7.0%).

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

United Bankshares, Inc. is a bank holding company dual-headquartered in Charleston, West Virginia and Fairfax, Virginia with operations in West Virginia, Virginia, the District of Columbia, Maryland, Ohio, Pennsylvania, North Carolina, South Carolina, and Georgia in the United States. United Bankshares is the parent company of United Bank which comprises nearly 250 offices in eight states. In addition, UBSI is the parent company to subsidiaries George Mason Mortgage, United Brokerage, and Cre...

NPCE vs VABK — Head-to-Head

Bigger by revenue
NPCE
NPCE
1.8× larger
NPCE
$26.6M
$15.0M
VABK
Growing faster (revenue YoY)
NPCE
NPCE
+20.3% gap
NPCE
23.9%
3.6%
VABK
Higher net margin
VABK
VABK
49.9% more per $
VABK
39.7%
-10.3%
NPCE
More free cash flow
VABK
VABK
$20.3M more FCF
VABK
$20.8M
$409.0K
NPCE
Faster 2-yr revenue CAGR
NPCE
NPCE
Annualised
NPCE
21.1%
7.0%
VABK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NPCE
NPCE
VABK
VABK
Revenue
$26.6M
$15.0M
Net Profit
$-2.7M
$6.0M
Gross Margin
77.4%
Operating Margin
-6.6%
50.5%
Net Margin
-10.3%
39.7%
Revenue YoY
23.9%
3.6%
Net Profit YoY
48.0%
30.6%
EPS (diluted)
$-0.08
$1.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPCE
NPCE
VABK
VABK
Q4 25
$26.6M
$15.0M
Q3 25
$27.4M
$14.4M
Q2 25
$23.5M
$14.1M
Q1 25
$22.5M
$14.1M
Q4 24
$21.5M
$14.5M
Q3 24
$21.1M
$13.5M
Q2 24
$19.3M
$12.9M
Q1 24
$18.1M
$13.1M
Net Profit
NPCE
NPCE
VABK
VABK
Q4 25
$-2.7M
$6.0M
Q3 25
$-3.5M
$4.6M
Q2 25
$-8.7M
$4.2M
Q1 25
$-6.6M
$4.5M
Q4 24
$-5.3M
$4.6M
Q3 24
$-5.5M
$4.6M
Q2 24
$-7.5M
$4.2M
Q1 24
$-8.9M
$3.6M
Gross Margin
NPCE
NPCE
VABK
VABK
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
NPCE
NPCE
VABK
VABK
Q4 25
-6.6%
50.5%
Q3 25
-9.5%
39.4%
Q2 25
-29.0%
38.4%
Q1 25
-22.9%
38.4%
Q4 24
-17.0%
40.3%
Q3 24
-20.1%
41.9%
Q2 24
-32.4%
39.5%
Q1 24
-41.6%
32.9%
Net Margin
NPCE
NPCE
VABK
VABK
Q4 25
-10.3%
39.7%
Q3 25
-12.8%
31.7%
Q2 25
-36.8%
30.0%
Q1 25
-29.3%
31.9%
Q4 24
-24.5%
31.4%
Q3 24
-25.9%
34.1%
Q2 24
-39.0%
32.3%
Q1 24
-49.2%
27.8%
EPS (diluted)
NPCE
NPCE
VABK
VABK
Q4 25
$-0.08
$1.10
Q3 25
$-0.11
$0.84
Q2 25
$-0.26
$0.78
Q1 25
$-0.21
$0.83
Q4 24
$-0.16
$0.85
Q3 24
$-0.19
$0.85
Q2 24
$-0.26
$0.77
Q1 24
$-0.32
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPCE
NPCE
VABK
VABK
Cash + ST InvestmentsLiquidity on hand
$61.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$19.0M
$184.2M
Total Assets
$105.6M
$1.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPCE
NPCE
VABK
VABK
Q4 25
$61.1M
Q3 25
$60.0M
Q2 25
$62.1M
Q1 25
$66.3M
Q4 24
$52.8M
Q3 24
$56.8M
Q2 24
$55.5M
Q1 24
$58.9M
Stockholders' Equity
NPCE
NPCE
VABK
VABK
Q4 25
$19.0M
$184.2M
Q3 25
$18.5M
$177.4M
Q2 25
$19.4M
$170.8M
Q1 25
$24.3M
$166.8M
Q4 24
$8.0M
$160.3M
Q3 24
$9.8M
$165.9M
Q2 24
$9.9M
$154.2M
Q1 24
$14.3M
$152.6M
Total Assets
NPCE
NPCE
VABK
VABK
Q4 25
$105.6M
$1.6B
Q3 25
$107.3M
$1.6B
Q2 25
$106.1M
$1.6B
Q1 25
$110.2M
$1.6B
Q4 24
$94.6M
$1.6B
Q3 24
$96.3M
$1.6B
Q2 24
$94.4M
$1.6B
Q1 24
$98.9M
$1.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NPCE
NPCE
VABK
VABK
Operating Cash FlowLast quarter
$506.0K
$21.3M
Free Cash FlowOCF − Capex
$409.0K
$20.8M
FCF MarginFCF / Revenue
1.5%
138.2%
Capex IntensityCapex / Revenue
0.4%
3.9%
Cash ConversionOCF / Net Profit
3.58×
TTM Free Cash FlowTrailing 4 quarters
$-11.3M
$35.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NPCE
NPCE
VABK
VABK
Q4 25
$506.0K
$21.3M
Q3 25
$-1.9M
$6.0M
Q2 25
$-2.1M
$6.7M
Q1 25
$-7.5M
$2.1M
Q4 24
$-4.8M
$15.3M
Q3 24
$-1.7M
$15.2M
Q2 24
$-3.9M
$-6.4M
Q1 24
$-7.5M
$3.2M
Free Cash Flow
NPCE
NPCE
VABK
VABK
Q4 25
$409.0K
$20.8M
Q3 25
$-2.0M
$5.9M
Q2 25
$-2.3M
$6.7M
Q1 25
$-7.5M
$1.8M
Q4 24
$-4.8M
$14.6M
Q3 24
$-1.8M
$15.1M
Q2 24
$-4.0M
$-6.8M
Q1 24
$-7.6M
$3.1M
FCF Margin
NPCE
NPCE
VABK
VABK
Q4 25
1.5%
138.2%
Q3 25
-7.2%
41.0%
Q2 25
-9.6%
47.6%
Q1 25
-33.4%
13.0%
Q4 24
-22.5%
100.4%
Q3 24
-8.7%
111.7%
Q2 24
-20.6%
-53.0%
Q1 24
-42.1%
23.9%
Capex Intensity
NPCE
NPCE
VABK
VABK
Q4 25
0.4%
3.9%
Q3 25
0.1%
0.5%
Q2 25
0.7%
0.2%
Q1 25
0.2%
1.8%
Q4 24
0.2%
5.1%
Q3 24
0.5%
0.9%
Q2 24
0.3%
3.1%
Q1 24
0.6%
0.2%
Cash Conversion
NPCE
NPCE
VABK
VABK
Q4 25
3.58×
Q3 25
1.31×
Q2 25
1.59×
Q1 25
0.47×
Q4 24
3.35×
Q3 24
3.30×
Q2 24
-1.54×
Q1 24
0.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons